Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

about

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

Item

http://www.wikidata.org/entity/Q58565355

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@en

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@nl

type

Item

label

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@en

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@nl

prefLabel

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@en

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@nl

P1476

Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma

@en

P2093

Gang Huang

http://www.w3.org/2001/XMLSchema#string

Hongyi Liao

http://www.w3.org/2001/XMLSchema#string

Xianbiao Xie

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Functional Role of G9a Histone Methyltransferase in Cancer

Management of Ewing sarcoma family of tumors: Current scenario and unmet need

S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component

Moonlighting cell-surface GAPDH recruits apotransferrin to effect iron egress from mammalian cells

Mammalian TIMELESS and Tipin are evolutionarily conserved replication fork-associated factors

A novel protein complex distinct from mismatch repair binds thioguanylated DNA.

Regulation of oncogenic transcription factor hTAF(II)68-TEC activity by human glyceraldehyde-3-phosphate dehydrogenase (GAPDH).

TIMELESS contributes to the progression of breast cancer through activation of MYC.

Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control.

Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

P304

6947-6956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S172190

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410352

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6199211

http://www.w3.org/2001/XMLSchema#string